Literature DB >> 2060516

Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

F H Kayser1, J Wüst.   

Abstract

Sparfloxacin disk susceptibility test criteria for the NCCLS and ICS/DIN methods were determined by testing 400 bacterial wild-type isolates. Disks containing 5 micrograms of the drug could be used satisfactorily in both procedures. The following interpretive zone size breakpoints for the NCCLS and ICS/DIN methods were proposed: less than or equal to 18 and 20 mm respectively for resistance (MIC greater than 1 mg/l), and greater than or equal to 23 and 25 mm respectively for susceptibility (MIC less than or equal to 0.5 mg/l). These criteria were based on preliminary maximum serum concentrations of approximately 1.5 mg/l after a single oral dose of 400 mg of the drug. Regression equations for both methods correlating MICs and zone sizes based on test results for 361 organisms are presented. The equations allow calculation of breakpoints for higher or lower serum peak levels. Sparfloxacin was two to four times more active than ciprofloxacin against gram-positive cocci, and showed equal activity against gram-negative rods. Zone diameter quality control values for Escherichia coli ATCC 25922 were 26-30 mm (NCCLS) and 30-33 mm (ICS/DIN), and for Staphylococcus aureus ATCC 29213 27-28 mm (NCCLS) and 29-31 mm (ICS/DIN).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060516     DOI: 10.1007/bf01964449

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  2 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.

Authors:  S Nakamura; A Minami; K Nakata; N Kurobe; K Kouno; Y Sakaguchi; S Kashimoto; H Yoshida; T Kojima; T Ohue
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

  2 in total
  4 in total

1.  Tissue penetration of sparfloxacin in a rat model of experimental Escherichia coli epididymitis.

Authors:  M Ludwig; C A Jantos; S Wolf; M Bergmann; K Failing; H G Schiefer; W Weidner
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

2.  Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland.

Authors:  J Wüst; E Huf; F H Kayser
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

3.  Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Authors:  P C Fuchs; A L Barry; M A Pfaller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

4.  Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates.

Authors:  L D Sutton; R N Jones
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.